Skip to content
Pharma Observatory a Scientist.com platform
  • Trial site

Trial site location from the registry's own city and country. GeoNames (geonames.org).

Clinical trial site

University of California, San Francisco

University of California, San Francisco in San Francisco, California, United States is listed as a site for 2,343 registered clinical trials, 749 of them ongoing.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Registered trials 2,343
Ongoing 749

This page covers the site record University of California, San Francisco in San Francisco, California, United States: the trials that list it by this name in ClinicalTrials.gov. The same place can be registered under other names, each with its own page and its own trials, and a count here is a number of registered trials, not of patients enrolled. The organization of the same name, University of California, San Francisco, also sponsors trials.

Get the University of California, San Francisco report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Trials by phase

Registered trials that list this site, by trial phase. 2,343 trials counted.

  • Phase 1 258 trials
  • Phase 1/2 139 trials
  • Phase 2 478 trials
  • Phase 2/3 48 trials
  • Phase 3 263 trials
  • Phase 4 110 trials
  • Not applicable 608 trials
  • Observational 424 trials
  • Expanded access 15 trials

Trials by status

The registry's own status summary: Ongoing, Completed, Terminated or Other.

  • Ongoing 751 trials
  • Completed 1,193 trials
  • Terminated 329 trials
  • Other 70 trials

Trials over time

Trials registered with a start date in each year, 1990 onward, most recent years first.

Trials over time, by phase

  • Phase 1
  • Phase 1/2
  • Phase 2
  • Phase 2/3
  • Phase 3
  • Phase 4
  • Not applicable
  • Observational

Top of scale: 148

1992: 1 trials (Phase 3 1) 1993: 2 trials (Observational 1, Phase 3 1) 1994: 1 trials (Observational 1) 1995: 3 trials (Observational 1, Phase 3 2) 1997: 2 trials (Observational 1, Phase 3 1) 1998: 4 trials (Observational 3, Phase 3 1) 1999: 9 trials (Observational 3, Not applicable 1, Phase 3 1, Phase 2/3 1, Phase 2 2, Phase 1/2 1) 2000: 13 trials (Observational 4, Not applicable 3, Phase 4 3, Phase 3 2, Phase 2/3 1) 2001: 11 trials (Observational 5, Phase 3 2, Phase 2/3 1, Phase 2 2, Phase 1 1) 2002: 20 trials (Observational 1, Not applicable 2, Phase 3 3, Phase 2/3 2, Phase 2 7, Phase 1/2 4, Phase 1 1) 2003: 18 trials (Observational 4, Not applicable 1, Phase 4 2, Phase 3 2, Phase 2/3 1, Phase 2 5, Phase 1/2 2, Phase 1 1) 2004: 35 trials (Observational 6, Not applicable 5, Phase 3 7, Phase 2 8, Phase 1/2 5, Phase 1 4) 2005: 48 trials (Observational 12, Not applicable 8, Phase 4 3, Phase 3 7, Phase 2 14, Phase 1/2 3, Phase 1 1) 2006: 41 trials (Observational 8, Not applicable 4, Phase 4 1, Phase 3 7, Phase 2 11, Phase 1/2 4, Phase 1 6) 2007: 61 trials (Observational 8, Not applicable 13, Phase 4 1, Phase 3 9, Phase 2/3 1, Phase 2 19, Phase 1/2 4, Phase 1 6) 2008: 55 trials (Observational 11, Not applicable 11, Phase 4 3, Phase 3 7, Phase 2/3 2, Phase 2 15, Phase 1/2 2, Phase 1 4) 2009: 61 trials (Observational 13, Not applicable 12, Phase 4 3, Phase 3 9, Phase 2/3 1, Phase 2 16, Phase 1/2 2, Phase 1 5) 2010: 84 trials (Observational 23, Not applicable 14, Phase 4 2, Phase 3 16, Phase 2/3 2, Phase 2 12, Phase 1/2 5, Phase 1 10) 2011: 63 trials (Observational 16, Not applicable 14, Phase 4 2, Phase 3 5, Phase 2/3 1, Phase 2 17, Phase 1/2 1, Phase 1 7) 2012: 84 trials (Observational 13, Not applicable 22, Phase 4 11, Phase 3 11, Phase 2/3 2, Phase 2 10, Phase 1/2 5, Phase 1 10) 2013: 69 trials (Observational 8, Not applicable 21, Phase 4 1, Phase 3 7, Phase 2/3 1, Phase 2 24, Phase 1/2 3, Phase 1 4) 2014: 90 trials (Observational 16, Not applicable 27, Phase 4 2, Phase 3 9, Phase 2/3 1, Phase 2 17, Phase 1/2 5, Phase 1 13) 2015: 107 trials (Observational 17, Not applicable 23, Phase 4 2, Phase 3 9, Phase 2/3 5, Phase 2 25, Phase 1/2 4, Phase 1 22) 2016: 109 trials (Observational 16, Not applicable 28, Phase 4 6, Phase 3 8, Phase 2/3 6, Phase 2 21, Phase 1/2 5, Phase 1 19) 2017: 125 trials (Observational 21, Not applicable 30, Phase 4 3, Phase 3 23, Phase 2/3 1, Phase 2 29, Phase 1/2 6, Phase 1 12) 2018: 142 trials (Observational 20, Not applicable 37, Phase 4 6, Phase 3 15, Phase 2/3 3, Phase 2 36, Phase 1/2 9, Phase 1 16) 2019: 129 trials (Observational 16, Not applicable 39, Phase 4 6, Phase 3 15, Phase 2/3 3, Phase 2 22, Phase 1/2 10, Phase 1 18) 2020: 140 trials (Observational 39, Not applicable 39, Phase 4 9, Phase 3 7, Phase 2/3 1, Phase 2 25, Phase 1/2 5, Phase 1 15) 2021: 129 trials (Observational 29, Not applicable 28, Phase 4 8, Phase 3 13, Phase 2/3 2, Phase 2 25, Phase 1/2 6, Phase 1 18) 2022: 148 trials (Observational 21, Not applicable 40, Phase 4 11, Phase 3 14, Phase 2/3 2, Phase 2 30, Phase 1/2 16, Phase 1 14) 2023: 129 trials (Observational 23, Not applicable 52, Phase 4 7, Phase 3 8, Phase 2/3 4, Phase 2 17, Phase 1/2 5, Phase 1 13) 2024: 134 trials (Observational 26, Not applicable 39, Phase 4 7, Phase 3 16, Phase 2/3 1, Phase 2 21, Phase 1/2 10, Phase 1 14) 2025: 132 trials (Observational 25, Not applicable 46, Phase 4 3, Phase 3 15, Phase 2/3 1, Phase 2 22, Phase 1/2 6, Phase 1 14)

Trials that list this site and are registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table). The table below lists the same counts, most recent years first.

Trials started per year
Year Trials started
2026 (partial year) 116
2025 132
2024 134
2023 129
2022 148
2021 129
2020 140
2019 129
2018 142
2017 125

Showing 10 of 34 years.

Start your 14-day trial Email me all 34 years as a PDF

2026 is partial: trials registered with a 2026 start date so far, not a full year. 8 trials are registered to start in 2027 or later, and not listed here

Recent trials

The newest registered trials that list this site. Each title opens its ClinicalTrials.gov record.

Showing 5 of 2,343 trials.

Start your 14-day trial Email me the first 50 trials as a PDF

Source: ClinicalTrials.gov

Lead sponsors

Most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.

Showing 5 of 420 lead sponsors.

Start your 14-day trial Email me the first 50 lead sponsors as a PDF

Conditions studied

The specific conditions of the trials that list this site, most trials first.

Showing 5 of 895 conditions.

Start your 14-day trial Email me the first 50 conditions as a PDF